Completed NA INTERVENTIONAL 3-arm NCT00289289

Reducing Episodes by Septal Pacing Efficacy Confirmation Trial (RESPECT)

Sponsor: Medtronic Cardiac Rhythm and Heart Failure

Conditions Arrhythmia Atrial Fibrillation Bradycardia Tachycardia, Supraventricular

Interventions Intervention Pacing Features

Updated 7 times since 2017 Last updated: Jun 25, 2012 Started: Feb 29, 2004 Primary completion: Nov 30, 2010 Completion: Jul 31, 2011

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00289289, this NA trial focuses on Arrhythmia and Atrial Fibrillation and remains completed. Sponsored by Medtronic Cardiac Rhythm and Heart Failure, it has been updated 7 times since 2004, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Dec 2021 — Jul 2024 [monthly]

Completed NA
Jan 2021 — Dec 2021 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA

▶ Show 2 earlier versions

Feb 2017 — Jun 2018 [monthly]

Completed NA
Jan 2017 — Feb 2017 [monthly]

Completed NA

First recorded

Feb 2004

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Medtronic Cardiac Rhythm and Heart Failure

Data source: Medtronic Cardiac Rhythm and Heart Failure

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Albuquerque, United States , Amarillo, United States , Austin, United States , Burlington, United States , Cedar Rapids, United States , Charlotte, United States , Chicago, United States , Cleveland, United States , Clifton, United States , Colorado Springs, United States and 28 more locations